SNGX
Soligenix, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website oligenix.com
- Employees(FY) 13
- ISIN US8342235053
Performance
-3.3%
1W
-16.82%
1M
-43.02%
3M
-2.89%
6M
-48.15%
YTD
-49.67%
1Y
Profile
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease; and SGX302 that is in Phase IIa clinical trial for the treatment of mild-to-moderate psoriasis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
Technical Analysis of SNGX 2024-05-10
Overview:
In analyzing the technical indicators for SNGX over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...
Recent News & Updates
- 2024-05-15 19:30
- 2024-05-12 22:54
- 2024-05-09 19:30
- 2024-05-05 19:30
Soligenix to Present at Upcoming Conferences(Prnewswire)
- 2024-04-24 19:30
- 2024-04-17 20:30
- 2024-04-15 03:55
Why Is Penny Stock Soligenix Trading Higher On Monday?(Yahoo Finance)
- 2024-04-14 23:18
Why Is Soligenix (SNGX) Stock Up 58% Today?(Investorplace)
- 2024-04-14 19:30
- 2024-04-10 19:30
- 2024-04-02 19:30
- 2024-03-15 01:53
- 2024-03-14 19:30
- 2024-02-07 18:30
- 2024-01-25 20:00
- 2024-01-24 18:30
Soligenix to Present at The Microcap Conference(Prnewswire)
- 2024-01-07 18:30
- 2024-01-03 18:30
- 2024-01-01 18:30
- 2023-11-30 18:30
- 2023-11-29 22:07
Why Is Soligenix (SNGX) Stock Up 285% Today?(Investorplace)
- 2023-11-29 18:30
- 2023-11-17 03:00
- 2023-11-12 19:12
Soligenix Q3 Loss Narrows(Rttnews)
- 2023-11-12 18:30
- 2023-10-20 04:00
- 2023-10-19 21:00
- 2023-10-15 19:30
- 2023-10-12 21:00
- 2023-10-05 21:00
Page 1 of 4
previousnext